Koh Nakata

Koh Nakata

Niigata University

H-index: 51

Asia-Japan

About Koh Nakata

Koh Nakata, With an exceptional h-index of 51 and a recent h-index of 33 (since 2020), a distinguished researcher at Niigata University, specializes in the field of pulmonary medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Usefulness and Safety of Long-Term GM-CSF Inhalation Therapy for Autoimmune Pulmonary Alveolar Proteinosis

The clinical importance of pulmonary gene and protein expression levels in an infant with lethal ABCA3 variants

Two-year cohort study after GM-CSF inhalation therapy for autoimmune pulmonary alveolar proteinosis

Exploring the prognosis and pathogenesis of secondary pulmonary alveolar proteinosis

Quantitative evaluation of changes in three-dimensional CT density distributions in pulmonary alveolar proteinosis after GM-CSF inhalation

Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 pneumonia: a double-blind, randomised, placebo …

Characterization of the cellular heterogeneity and bone regenerative potential of cultured human periosteal cells

Non-destructive, spectrophotometric analysis of the thickness of the cell-multilayered periosteal sheet

Koh Nakata Information

University

Position

Division of Pioneering Advanced Therapeutics Medical & Dental Hospital

Citations(all)

11616

Citations(since 2020)

4161

Cited By

9158

hIndex(all)

51

hIndex(since 2020)

33

i10Index(all)

118

i10Index(since 2020)

83

Email

University Profile Page

Niigata University

Google Scholar

View Google Scholar Profile

Koh Nakata Skills & Research Interests

pulmonary medicine

Top articles of Koh Nakata

Title

Journal

Author(s)

Publication Date

Usefulness and Safety of Long-Term GM-CSF Inhalation Therapy for Autoimmune Pulmonary Alveolar Proteinosis

S Ohkouchi

R Tazawa

T Irokawa

H Ogawa

H Kurosawa

...

2024/5

The clinical importance of pulmonary gene and protein expression levels in an infant with lethal ABCA3 variants

Pediatric pulmonology

Jiro Abe

Masahiro Ueki

Ryota Honjou

Kenta Takeda

Yoshitaka Seto

...

2023/10

Two-year cohort study after GM-CSF inhalation therapy for autoimmune pulmonary alveolar proteinosis

Koh Nakata

Ryushi Tazawa

Nobutaka Kitamura

Haruyuki Ishii

Page Research Group

2023/9/9

Exploring the prognosis and pathogenesis of secondary pulmonary alveolar proteinosis

Haruyuki Ishii

Ryushi Tazawa

Tomohiro Handa

Yoshinori Tanino

Nobutaka Kitamura

...

2023/9/9

Quantitative evaluation of changes in three-dimensional CT density distributions in pulmonary alveolar proteinosis after GM-CSF inhalation

Respiration

Miku Oda

Kentaro Yamaura

Haruyuki Ishii

Nobutaka Kitamura

Ryushi Tazawa

...

2023/2/3

Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 pneumonia: a double-blind, randomised, placebo …

Infectious Diseases

Shigeki Shimasaki

Tomohisa Baba

Takashi Ogura

Keiichi Akasaka

Hidekazu Matsushima

...

2023/12/2

Characterization of the cellular heterogeneity and bone regenerative potential of cultured human periosteal cells

Regenerative Therapy

Takahiro Tsuzuno

Naoki Takahashi

Masaki Nagata

Yuta Ueda

Shunya Motosugi

...

2023/12/1

Non-destructive, spectrophotometric analysis of the thickness of the cell-multilayered periosteal sheet

International Journal of Implant Dentistry

Hachidai Aizawa

Takashi Uematsu

Atsushi Sato

Hideo Masuki

Hideo Kawabata

...

2022/5/2

Fluorometric quantification of human platelet polyphosphate using 4′, 6-diamidine-2-phenylindole dihydrochloride: Applications in the Japanese population

International Journal of Molecular Sciences

Taisuke Watanabe

Yutaka Kitamura

Hachidai Aizawa

Hideo Masuki

Tetsuhiro Tsujino

...

2021/7/6

Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis

Nature communications

Saori Sakaue

Etsuro Yamaguchi

Yoshikazu Inoue

Meiko Takahashi

Jun Hirata

...

2021/2/15

Proteogenomic analysis of granulocyte macrophage colony-stimulating factor autoantibodies in the blood of a patient with autoimmune pulmonary alveolar proteinosis

Scientific Reports

Atsushi Hashimoto

Shiho Takeuchi

Ryo Kajita

Akira Yamagata

Ryota Kakui

...

2020/3/18

Improvement of native pulmonary alveolar proteinosis after contralateral single living‐donor lobar lung transplantation: A case report

Pediatric Transplantation

Kazuma Kobayashi

Shinya Ohkouchi

Yoji Sasahara

Masahito Ebina

Koh Nakata

...

2020/3

The Efficacy of GM-CSF Inhalation for Autoimmune Pulmonary Alveolar Proteinosis Is Influenced by Smoking Status

N Kitamura

R Tazawa

K Nakata

PAGE Research Group

2020/5

A comparative study of the effects of anticoagulants on pure platelet-rich plasma quality and potency

Biomedicines

Hachidai Aizawa

Hideo Kawabata

Atsushi Sato

Hideo Masuki

Taisuke Watanabe

...

2020/2/25

Antibody Against Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Inhaled GM-CSF for Pulmonary Alveolar Proteinosis

R Tazawa

T Ueda

M Abe

K Tatsumi

R Eda

...

2020/5

Validation of a new serum granulocyte–macrophage colony-stimulating factor autoantibody testing kit

ERJ Open Research

Koh Nakata

Tatsuki Sugi

Keiko Kuroda

Kazutaka Yoshizawa

Toshinori Takada

...

2020/1/1

Secondary pulmonary alveolar proteinosis following treatment with azacitidine for myelodysplastic syndrome

Chest

Ahmad Sharayah

Shannon E Burke

Huazhang Guo

David A Stoeckel

2022/10/1

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. Reply.

The New England journal of medicine

Ryushi Tazawa

Nobutaka Kitamura

Koh Nakata

2020/1/1

See List of Professors in Koh Nakata University(Niigata University)